应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06833 兴科蓉医药
未开盘 06-08 15:00:00
0.170
+0.004
+2.41%
最高
0.170
最低
0.170
成交量
4,000
今开
0.170
昨收
0.166
日振幅
0.00%
总市值
3.46亿
流通市值
3.46亿
总股本
20.33亿
成交额
680.00
换手率
0.00%
流通股本
20.33亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
兴科蓉医药5月无新增发行或股份变动
公告速递 · 06-01
兴科蓉医药5月无新增发行或股份变动
兴科蓉医药控股有限公司委任黄志坚为董事会及提名委员会主席,自2026年5月22日起生效
美股速递 · 05-22
兴科蓉医药控股有限公司委任黄志坚为董事会及提名委员会主席,自2026年5月22日起生效
兴科蓉医药(06833):黄智健获委任为董事会主席兼董事会提名委员会主席
智通财经 · 05-22
兴科蓉医药(06833):黄智健获委任为董事会主席兼董事会提名委员会主席
兴科蓉医药4月股份变动月报表:股本维持不变
公告速递 · 05-06
兴科蓉医药4月股份变动月报表:股本维持不变
兴科蓉医药(06833):黄祥彬辞任董事会主席、执行董事
智通财经 · 04-30
兴科蓉医药(06833):黄祥彬辞任董事会主席、执行董事
兴科蓉医药授予董事股份购回授权,规模达已发行股本一成
公告速递 · 04-20
兴科蓉医药授予董事股份购回授权,规模达已发行股本一成
兴科蓉医药3月股份变动月报表,股本维持稳定
公告速递 · 04-01
兴科蓉医药3月股份变动月报表,股本维持稳定
兴科蓉医药将于2026年6月4日派发末期股息每股0.00167港元
公告速递 · 03-27
兴科蓉医药将于2026年6月4日派发末期股息每股0.00167港元
兴科蓉医药2025年收入下滑但毛利率稳定 经营现金流由负转正
公告速递 · 03-26
兴科蓉医药2025年收入下滑但毛利率稳定 经营现金流由负转正
兴科蓉医药(06833)发布年度业绩 股东应占纯利3490万元 同比减少16.9%
智通财经 · 03-26
兴科蓉医药(06833)发布年度业绩 股东应占纯利3490万元 同比减少16.9%
兴科蓉医药将于2026年06月04日派发末期股息每股0.167港元
公告速递 · 03-26
兴科蓉医药将于2026年06月04日派发末期股息每股0.167港元
兴科蓉医药盘中异动 快速拉升5.29%
市场透视 · 03-09
兴科蓉医药盘中异动 快速拉升5.29%
兴科蓉医药控股(06833)2月股份变动月报:股本维持不变
公告速递 · 03-02
兴科蓉医药控股(06833)2月股份变动月报:股本维持不变
兴科蓉医药盘中异动 快速下跌10.38%
市场透视 · 02-13
兴科蓉医药盘中异动 快速下跌10.38%
兴科蓉医药盘中异动 快速上涨9.82%
市场透视 · 01-16
兴科蓉医药盘中异动 快速上涨9.82%
兴科蓉医药盘中异动 急速上涨5.56%
市场透视 · 01-12
兴科蓉医药盘中异动 急速上涨5.56%
兴科蓉医药盘中异动 早盘急速下跌8.25%
市场透视 · 2025-03-11
兴科蓉医药盘中异动 早盘急速下跌8.25%
兴科蓉医药盘中异动 早盘大幅拉升5.98%报0.195港元
市场透视 · 2025-03-05
兴科蓉医药盘中异动 早盘大幅拉升5.98%报0.195港元
兴科蓉医药盘中异动 下午盘快速拉升6.08%报0.192港元
市场透视 · 2025-03-04
兴科蓉医药盘中异动 下午盘快速拉升6.08%报0.192港元
兴科蓉医药盘中异动 股价大跌6.91%报0.175港元
市场透视 · 2025-03-03
兴科蓉医药盘中异动 股价大跌6.91%报0.175港元
加载更多
公司概况
公司名称:
兴科蓉医药
所属市场:
SEHK
上市日期:
--
主营业务:
兴科蓉医药控股有限公司是一家主要从事为进口药品及医疗器械提供综合性营销、推广及渠道管理服务的投资控股公司。该公司主要运营三个分部。进口药品销售分部从事销售改善人体血浆药品、抗生素及关注治疗领域与人体血浆制品及其他类别互补的其他药品的市场营销、推广及渠道管理活动。医美药物研究及制造分部从事研发及制造医美药物业务。医美服务分部提供医美服务。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06833","market":"HK","secType":"STK","nameCN":"兴科蓉医药","latestPrice":0.17,"timestamp":1780902000578,"preClose":0.166,"halted":0,"volume":4000,"delay":0,"changeRate":0.024096385542168693,"floatShares":2032890585,"shares":2032999999,"eps":0.01963775646149747,"marketStatus":"未开盘","change":0.004,"latestTime":"06-08 15:00:00","open":0.17,"high":0.17,"low":0.17,"amount":680,"amplitude":0,"askPrice":0.188,"askSize":24000,"bidPrice":0.168,"bidSize":20000,"shortable":0,"etf":0,"ttmEps":0.01963775646149747,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780968600000},"marketStatusCode":0,"adr":0,"listingDate":1457539200000,"exchange":"SEHK","adjPreClose":0.166,"dividendRate":0.010165,"openAndCloseTimeList":[[1780882200000,1780891200000],[1780894800000,1780905600000]],"volumeRatio":0.008880994670417296,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06833","defaultTab":"news","newsList":[{"id":"1144512171","title":"兴科蓉医药5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1144512171","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144512171?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:50","pubTimestamp":1780303828,"startTime":"0","endTime":"0","summary":"兴科蓉医药控股有限公司于2026年6月1日发布了截至2026年5月31日的月度报告。本月期间,公司已发行股份数量为2,032,890,585股,较上月底无变化,库存股份数依旧为0股。公司声明,所有股份发行及库存股份事项均遵守香港联交所《上市规则》及相关法律规定,公告由公司秘书彭云璐签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107088607","title":"兴科蓉医药控股有限公司委任黄志坚为董事会及提名委员会主席,自2026年5月22日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1107088607","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107088607?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:43","pubTimestamp":1779439436,"startTime":"0","endTime":"0","summary":"兴科蓉医药控股有限公司(SINCO PHARMA)宣布,自2026年5月22日起,委任黄志坚先生为公司董事会主席及提名委员会主席。\n此项任命标志着公司治理结构的关键调整。黄志坚先生将肩负起领导董事会、制定公司战略方向以及监督提名委员会运作的重要职责。\n董事会相信,凭借其丰富的行业经验与领导力,黄志坚先生将为公司的长远发展注入新的动力,并进一步加强董事会的决策效能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637394429","title":"兴科蓉医药(06833):黄智健获委任为董事会主席兼董事会提名委员会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2637394429","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637394429?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:32","pubTimestamp":1779438774,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兴科蓉医药(06833)发布公告,公司现时的董事会副主席兼执行董事黄智健先生已获委任为董事会主席兼董事会提名委员会主席,自2026年5月22日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171308799","title":"兴科蓉医药4月股份变动月报表:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1171308799","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171308799?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:36","pubTimestamp":1778056580,"startTime":"0","endTime":"0","summary":"兴科蓉医药控股有限公司于2026年5月6日发布2026年4月证券变动月报表。报告显示,截至2026年4月30日,公司已发行股份及注册股本保持稳定,未有新增发行或回购注销行动。根据公告,兴科蓉医药的法定注册股本为1,000,000港元,股份总数为10,000,000,000股,面值为每股0.0001港元。兴科蓉医药表示,公司已遵守香港联交所《上市规则》及相关法律法规,并确认所有证券发行、库存股份出售或转让皆获得董事会授权和批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631631395","title":"兴科蓉医药(06833):黄祥彬辞任董事会主席、执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2631631395","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631631395?lang=zh_cn&edition=full","pubTime":"2026-04-30 19:40","pubTimestamp":1777549251,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兴科蓉医药(06833)发布公告,黄祥彬先生因拟投入更多时间及精力于彼之其他业务承担而提呈辞任董事会主席、执行董事、董事会提名委员会主席及香港联合交易所有限公司证券上市规则第3.05条项下的公司授权代表,自2026年4月30日起生效。黄智健先生已获委任为授权代表,自2026年4月30日起生效。彼目前为董事会副主席兼执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147299413","title":"兴科蓉医药授予董事股份购回授权,规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1147299413","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147299413?lang=zh_cn&edition=full","pubTime":"2026-04-20 19:15","pubTimestamp":1776683750,"startTime":"0","endTime":"0","summary":"兴科蓉医药公告显示,该公司将提请股东大会授予股份购回授权,最高可回购不超过已发行股本总数的10%。公告提及,只有在董事会认为符合公司及股东整体利益时才会进行股份购回。为确定参会资格,公司股东名册自5月12日至15日暂停办理过户。若获得批准,董事会可在合法期间内酌情行使相关权力。公告称,回购计划最终仍需配合市场环境及公司资金状况执行。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177830848","title":"兴科蓉医药3月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1177830848","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177830848?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:57","pubTimestamp":1775033862,"startTime":"0","endTime":"0","summary":"兴科蓉医药于2026年4月1日披露了截至2026年3月31日的股份变动月报表。公告显示,公司确认截至本月末,已满足香港联交所《上市规则》下的公众持股量要求,整体股本结构保持稳定。有关月报表由公司董事会主席黄祥彬签署,兴科蓉医药重申将持续遵守相关法律规定及香港联交所《上市规则》的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141333521","title":"兴科蓉医药将于2026年6月4日派发末期股息每股0.00167港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141333521","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141333521?lang=zh_cn&edition=full","pubTime":"2026-03-27 12:06","pubTimestamp":1774584371,"startTime":"0","endTime":"0","summary":"兴科蓉医药(06833)公告显示,董事会已宣派截至2025年12月31日止年度之末期股息,每股0.00167港元,尚待股东于2026年5月15日批准后方可生效。公司预定于2026年5月19日除净,并于2026年6月4日派发股息。\n公告同时显示,股份过户登记将于2026年5月21日至2026年5月26日期间暂时关闭,股权登记日为2026年5月26日。派息金额及货币单位均维持港元,相关汇率为1港元对1港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161620358","title":"兴科蓉医药2025年收入下滑但毛利率稳定 经营现金流由负转正","url":"https://stock-news.laohu8.com/highlight/detail?id=1161620358","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161620358?lang=zh_cn&edition=full","pubTime":"2026-03-26 21:45","pubTimestamp":1774532735,"startTime":"0","endTime":"0","summary":"兴科蓉医药于报告期内取得收入人民币20.85亿元,同比减少7.37亿元,降幅为26.1%。其中,人血白蛋白注射液收入约人民币20.64亿元,医美服务收入约人民币21.0百万元。公司整体毛利约为人民币2.22亿元,较上一年度减少人民币0.78亿元,毛利率则由10.6%微升至10.7%。期末银行借款总额降至人民币1.80亿元,杠杆比率从57.5%降低至52.2%。整体而言,公司收入及利润较上年度有所下滑,但毛利率基本保持稳定,银行借款及杠杆比率呈下降趋势,经营现金流由负转正。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622865508","title":"兴科蓉医药(06833)发布年度业绩 股东应占纯利3490万元 同比减少16.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622865508","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622865508?lang=zh_cn&edition=full","pubTime":"2026-03-26 21:44","pubTimestamp":1774532672,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兴科蓉医药(06833)发布截至2025年12月31日止年度业绩,该集团期内取得收益20.85亿元人民币,同比减少26.1%;公司拥有人应占纯利3490万元,同比减少16.9%;每股基本盈利0.017元;拟派发末期股息每股0.167港仙。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142305054","title":"兴科蓉医药将于2026年06月04日派发末期股息每股0.167港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142305054","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142305054?lang=zh_cn&edition=full","pubTime":"2026-03-26 21:42","pubTimestamp":1774532567,"startTime":"0","endTime":"0","summary":"兴科蓉医药(06833)\n根据公司于2026年3月26日发布的最新公告,该公司董事会建议派发截至2025年12月31日止年度的末期股息,每股0.167港元,尚待股东于2026年5月15日股东大会上批准。\n股息分派要点包括:2026年5月19日为除净日,股东如欲享有是次股息,须于2026年5月20日16时30分前办理股份过户手续。公司股份过户登记将于2026年5月21日至2026年5月26日暂停办理,记录日期为2026年5月26日。股息预计于2026年6月4日派发。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618401645","title":"兴科蓉医药盘中异动 快速拉升5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618401645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618401645?lang=zh_cn&edition=full","pubTime":"2026-03-09 14:23","pubTimestamp":1773037394,"startTime":"0","endTime":"0","summary":"2026年03月09日下午盘14时23分,兴科蓉医药股票出现波动,股价大幅拉升5.29%。截至发稿,该股报0.179港元/股,成交量18.8万股,换手率0.01%,振幅1.18%。兴科蓉医药股票所在的药品行业中,整体跌幅为0.66%。其相关个股中,劲方医药-B、海西新药、兴科蓉医药涨幅较大,振幅较大的相关个股有宝济药业-B、长风药业、英硅智能,振幅分别为30.67%、27.01%、16.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309142314a6b15a93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309142314a6b15a93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06833","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189819653","title":"兴科蓉医药控股(06833)2月股份变动月报:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1189819653","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189819653?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:48","pubTimestamp":1772441280,"startTime":"0","endTime":"0","summary":"兴科蓉医药控股有限公司于2026年3月2日发布截至2026年2月28日的股份变动月报表,披露报告期内公司已发行股份总数及股本结构未发生变化。公司法定注册股本为10,000,000,000股,面值每股0.0001港元,总额1,000,000港元。截至2月28日,已发行股份数为2,032,890,585股,与上月保持一致。公司无新增发行、购回、注销及库藏股份变动。公司在公告中声明已遵守香港联交所《上市规则》及相关法律法规。该公告由董事会主席黄祥彬正式签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611139998","title":"兴科蓉医药盘中异动 快速下跌10.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611139998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611139998?lang=zh_cn&edition=full","pubTime":"2026-02-13 13:12","pubTimestamp":1770959541,"startTime":"0","endTime":"0","summary":"2026年02月13日下午盘13时12分,兴科蓉医药股票出现波动,股价快速跳水10.38%。截至发稿,该股报0.164港元/股,成交量8.8万股,换手率0.00%,振幅0.00%。兴科蓉医药股票所在的药品行业中,整体涨幅为0.21%。其相关个股中,泰德医药、宝济药业-B、先声药业涨幅较大,振幅较大的相关个股有宝济药业-B、德琪医药-B、励晶太平洋,振幅分别为13.44%、10.95%、10.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602131312219540fe88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602131312219540fe88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604913159","title":"兴科蓉医药盘中异动 快速上涨9.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604913159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604913159?lang=zh_cn&edition=full","pubTime":"2026-01-16 13:59","pubTimestamp":1768543190,"startTime":"0","endTime":"0","summary":"2026年01月16日下午盘13时59分,兴科蓉医药股票出现异动,股价大幅拉升9.82%。截至发稿,该股报0.179港元/股,成交量12.8万股,换手率0.01%,振幅6.75%。兴科蓉医药股票所在的药品行业中,整体跌幅为0.28%。其相关个股中,兴科蓉医药、劲方医药-B、和黄医药涨幅较大,振幅较大的相关个股有劲方医药-B、励晶太平洋、德琪医药-B,振幅分别为9.73%、9.57%、9.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011613595097a20efd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011613595097a20efd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602278516","title":"兴科蓉医药盘中异动 急速上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602278516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602278516?lang=zh_cn&edition=full","pubTime":"2026-01-12 13:26","pubTimestamp":1768195584,"startTime":"0","endTime":"0","summary":"2026年01月12日下午盘13时26分,兴科蓉医药股票出现波动,股价快速上涨5.56%。兴科蓉医药股票所在的药品行业中,整体跌幅为0.19%。其相关个股中,英硅智能、兴科蓉医药、君圣泰医药-B涨幅较大,振幅较大的相关个股有英硅智能、先声药业、中国医疗集团,振幅分别为14.68%、14.16%、8.67%。兴科蓉医药公司简介:兴科蓉医药控股有限公司是一家主要从事为进口药品及医疗器械提供综合性营销、推广及渠道管理服务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112132625953c5dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112132625953c5dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518730671","title":"兴科蓉医药盘中异动 早盘急速下跌8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518730671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518730671?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:30","pubTimestamp":1741656610,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘09时30分,兴科蓉医药股票出现波动,股价快速下挫8.25%。截至发稿,该股报0.178港元/股,成交量4000股,换手率0.00%,振幅0.00%。兴科蓉医药股票所在的药品行业中,整体跌幅为0.10%。兴科蓉医药公司简介:兴科蓉医药控股有限公司是一家主要从事为进口药品及医疗器械提供综合性营销、推广及渠道管理服务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311093010abf4815f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311093010abf4815f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517611932","title":"兴科蓉医药盘中异动 早盘大幅拉升5.98%报0.195港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517611932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517611932?lang=zh_cn&edition=full","pubTime":"2025-03-05 09:40","pubTimestamp":1741138825,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时40分,兴科蓉医药股票出现异动,股价快速拉升5.98%。截至发稿,该股报0.195港元/股,成交量6.4万股,换手率0.00%,振幅9.24%。兴科蓉医药股票所在的药品行业中,整体涨幅为0.13%。其相关个股中,三生制药、兴科蓉医药、联邦制药涨幅较大,振幅较大的相关个股有兴科蓉医药、三生制药、联邦制药,振幅分别为9.24%、7.23%、6.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305094025989c5bce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305094025989c5bce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06833","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516161451","title":"兴科蓉医药盘中异动 下午盘快速拉升6.08%报0.192港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516161451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516161451?lang=zh_cn&edition=full","pubTime":"2025-03-04 13:13","pubTimestamp":1741065236,"startTime":"0","endTime":"0","summary":"2025年03月04日下午盘13时13分,兴科蓉医药股票出现波动,股价大幅拉升6.08%。截至发稿,该股报0.192港元/股,成交量31.6万股,换手率0.02%,振幅9.39%。资金方面,该股资金流入4.752万港元,流出9852港元。最近的财报数据显示,该股实现营业收入16.73亿港元,净利润2,615.37万港元,每股收益0.0128港元,毛利1.90亿港元,市盈率8.35倍。兴科蓉医药股票所在的药品行业中,整体跌幅为0.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304131356abe73539&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304131356abe73539&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06833","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516788095","title":"兴科蓉医药盘中异动 股价大跌6.91%报0.175港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516788095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516788095?lang=zh_cn&edition=full","pubTime":"2025-03-03 10:34","pubTimestamp":1740969263,"startTime":"0","endTime":"0","summary":"2025年03月03日早盘10时34分,兴科蓉医药股票出现异动,股价急速下跌6.91%。截至发稿,该股报0.175港元/股,成交量196万股,换手率0.10%,振幅3.19%。资金方面,该股资金流入32.5912万港元,流出1.6428万港元。最近的财报数据显示,该股实现营业收入16.73亿港元,净利润2,615.37万港元,每股收益0.0128港元,毛利1.90亿港元,市盈率7.61倍。兴科蓉医药股票所在的药品行业中,整体涨幅为0.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503031034239636d9ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503031034239636d9ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinco-pharm.com","stockEarnings":[{"period":"1week","weight":0.0241},{"period":"1month","weight":-0.0909},{"period":"3month","weight":-0.0659},{"period":"6month","weight":-0.0608},{"period":"1year","weight":-0.1282},{"period":"ytd","weight":-0.0286}],"compareEarnings":[{"period":"1week","weight":-0.0292},{"period":"1month","weight":-0.0658},{"period":"3month","weight":-0.0502},{"period":"6month","weight":-0.0346},{"period":"1year","weight":0.0363},{"period":"ytd","weight":-0.038}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"兴科蓉医药控股有限公司是一家主要从事为进口药品及医疗器械提供综合性营销、推广及渠道管理服务的投资控股公司。该公司主要运营三个分部。进口药品销售分部从事销售改善人体血浆药品、抗生素及关注治疗领域与人体血浆制品及其他类别互补的其他药品的市场营销、推广及渠道管理活动。医美药物研究及制造分部从事研发及制造医美药物业务。医美服务分部提供医美服务。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.040239},{"month":2,"riseRate":0.5,"avgChangeRate":0.108071},{"month":3,"riseRate":0.5,"avgChangeRate":0.034362},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.080007},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.043704},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.081267},{"month":7,"riseRate":0.5,"avgChangeRate":0.070944},{"month":8,"riseRate":0.2,"avgChangeRate":-0.173454},{"month":9,"riseRate":0.4,"avgChangeRate":-0.016059},{"month":10,"riseRate":0.6,"avgChangeRate":0.146469},{"month":11,"riseRate":0.4,"avgChangeRate":0.059625},{"month":12,"riseRate":0.7,"avgChangeRate":0.062745}],"exchange":"SEHK","name":"兴科蓉医药","nameEN":"SINCO PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"兴科蓉医药(06833)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供兴科蓉医药(06833)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"兴科蓉医药,06833,兴科蓉医药股票,兴科蓉医药股票老虎,兴科蓉医药股票老虎国际,兴科蓉医药行情,兴科蓉医药股票行情,兴科蓉医药股价,兴科蓉医药股市,兴科蓉医药股票价格,兴科蓉医药股票交易,兴科蓉医药股票购买,兴科蓉医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"兴科蓉医药(06833)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供兴科蓉医药(06833)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}